<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71288-745-21
</NDCCode>
<PackageDescription>
10 VIAL, SINGLE-USE in 1 CARTON (71288-745-21) / 20 mL in 1 VIAL, SINGLE-USE (71288-745-20)
</PackageDescription>
<NDC11Code>
71288-0745-21
</NDC11Code>
<ProductNDC>
71288-745
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Vecuronium Bromide
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Vecuronium Bromide
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20250701
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA074688
</ApplicationNumber>
<LabelerName>
Meitheal Pharmaceuticals Inc.
</LabelerName>
<SubstanceName>
VECURONIUM BROMIDE
</SubstanceName>
<StrengthNumber>
20
</StrengthNumber>
<StrengthUnit>
mg/20mL
</StrengthUnit>
<Pharm_Classes>
Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-07-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250701
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>